EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical Features of Brugada Syndrome Patients With SCN5A Variants

Sho Okamura iD, Hidenori Ochi, Mika Nakashima, Rie Akiyama, Takehito Tokuyama iD, Yousaku Okubo, Shunsuke Miyauchi iD, Shogo Miyamoto iD, Naoto Oguri iD, Yukimi Uotani, Takumi Sakai, Motoki Furutani und 2 weitere

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.16643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Sho Okamura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: NAV1.5 Voltage-Gated Sodium Channel, Brugada Syndrome, Heart Rate. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was funded by The Japan Society for the Promotion of Science (Grant number: 17K09501)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

SCN5A is the most common susceptibility gene in patients with Brugada syndrome (BrS); however, the interpretation and management of benign or variants of unknown clinical significance (VUS) in SCN5A remains a challenge despite the availability of genetic testing.

Objective

This study aimed to investigate the relationship between the SCN5A variants and clinical symptoms of BrS patients.

Methods

We resequenced the SCN5A gene in 239 patients diagnosed with BrS at Hiroshima University Hospital and analyzed the association between the SCN5A variants and clinical features, 12‐lead electrocardiography (ECG) parameters, and signal‐averaged ECG.

Results

Overall, 84 SCN5A variants were identified: 55 benign, 7 pathogenic, and 22 VUS. No significant difference in the incidence of previous cardiac events was observed between patients with and without SCA5A benign variants. The female proportion was higher in BrS patients with SCN5A VUS or pathogenic variants. Moreover, the symptomatic proportion was higher in BrS patients with SCN5A VUS or pathogenic variants than in those without SCN5A variants. Multivariate analyses revealed that the presence of SCN5A pathogenic variants, longer r‐J intervals in lead V1, and the presence of fragmented QRS were independently associated with cardiac events in BrS patients, and that positive late potentials, longer LAS40, and lower RMS40 were significantly associated with symptomatic BrS in patients carrying SCN5A VUS.

Conclusions

SCN5A pathogenic variants were found to be independent risk factors for cardiac events in BrS patients. Although SCN5A VUS was not an independent risk factor for cardiac events, proportion of symptomatic patients was higher in BrS patients with SCN5A VUS than in those without SCN5A variants. In BrS patients with SCN5A VUS, the signal‐averaged ECG was the key to the risk stratification for cardiac events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.5 Voltage-Gated Sodium ChannelBrugada SyndromeHeart RateHumansMaleFemaleMiddle AgedElectrocardiographyAdultGenetic Predisposition to DiseasePhenotypeRisk FactorsAction PotentialsJapanYoung AdultPredictive Value of TestsAgedRisk Assessment

Stichwörter der Autor:innen

Brugada syndromeSCN5A variantcardiac eventlate potentialsignal‐averaged ECG

Substanzen

NAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, human

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Health Management, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Department of Gastroenterology and Metabolism, Biomedical Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.

ORCID-Profile: Sho Okamura, Takehito Tokuyama, Shunsuke Miyauchi, Shogo Miyamoto, Naoto Oguri, Yukiko Nakano

Förderung

  • This study was funded by The Japan Society for the Promotion of Science (Grant number: 17K09501).

Zitieren

APA

Okamura, S., Ochi, H., Nakashima, M., Akiyama, R., Tokuyama, T., Okubo, Y., Miyauchi, S., Miyamoto, S., Oguri, N., Uotani, Y., Sakai, T., Furutani, M., Kihara, Y., & Nakano, Y. (2025). Clinical Features of Brugada Syndrome Patients With SCN5A Variants. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16643

Vancouver

Okamura S, Ochi H, Nakashima M, Akiyama R, Tokuyama T, Okubo Y, et al. Clinical Features of Brugada Syndrome Patients With SCN5A Variants. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16643

BibTeX
@article{Okamura2025,
  author = {Okamura, Sho and Ochi, Hidenori and Nakashima, Mika and Akiyama, Rie and Tokuyama, Takehito and Okubo, Yousaku and Miyauchi, Shunsuke and Miyamoto, Shogo and Oguri, Naoto and Uotani, Yukimi and Sakai, Takumi and Furutani, Motoki and Kihara, Yasuki and Nakano, Yukiko},
  title = {Clinical Features of Brugada Syndrome Patients With SCN5A Variants},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.16643}
}
Kostenlos starten →